|
[1]LOOMBA R, LING TJ. Hepatitis B reactivation associated with immune suppressive and biological modifier therapies:Current concepts, management strategies, and future directions[J].Gastroenterology, 2017, 152 (6) :1297-1309.
|
|
[2]COLUCCIO C, BEGINI P, MARZANO A, et al. Hepatitis B in patients with hematological diseases:An update[J]. World J Hepatol, 2017, 9 (25) :1043.
|
|
[3]CHOLONGITAS E, HAIDICH AB. Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy:A systematic review[J]. Ann Gastroenterol, 2018, 31 (4) :480-490.
|
|
[4]Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol, 2015, 31 (12) :1941-1960. (in Chinese) 中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南 (2015年更新版) [J].临床肝胆病杂志, 2015, 31 (12) :1941-1960.
|
|
[5]PISATURO M, DI CAPRIO G, CALF, et al. Management of HBV reactivation in non-oncological patients[J]. Expert Rev Anti Infect Ther, 2018, 16 (8) :611-624.
|
|
[6]AYGEN B, DEMIR AM, GMM, et al. Immunosuppressive therapy and the risk of hepatitis B reactivation:Consensus report[J]. Turk J Gastroenterol, 2018, 29 (3) :259-269.
|
|
[7]BESSONE F, DIRCHWORLF M. Management of hepatitis B reactivation in immunosuppressed patients:An update on current recommendations[J]. World J Hepatol, 2016, 8 (8) :385-394.
|
|
[8]DOH HK, SEOK BK. Hepatic failure by spontaneous reactivation of hepatitis B virus without a trigger factor in a patient with antiHBs[J]. Case Rep Gastroenterol, 2018, 12 (2) :286-291.
|
|
[9]DONG KH, FANG YN, KUI YW, et al. Management and prevention of HBV reactivation in the context of immunosuppression[J].J Clin Hepatol, 2018, 34 (10) :2213-2216. (in Chinese) 董凯惠, 方伊娜, 蒉乙文, 等.免疫抑制背景下HBV再激活的管理和预防[J].临床肝胆病杂志, 2018, 34 (10) :2213-2216.
|
|
[10]YU YC, HOU JL. The highlights of EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection[J]. J Clin Hepatol, 2017, 33 (6) :1017-1032. (in Chinese) 于乐成, 侯金林. 2017年欧洲肝病学会临床实践指南:HBV感染的管理 (精粹) [J].临床肝胆病杂志, 2017, 33 (6) :1017-1032.
|
DownLoad: